Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 8;546(7657):312-315.
doi: 10.1038/nature22378. Epub 2017 May 17.

Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators

Affiliations

Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators

Gaojie Song et al. Nature. .

Abstract

The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.

PubMed Disclaimer

Comment in

References

    1. Mol Endocrinol. 1997 Apr;11(4):424-32 - PubMed
    1. Biochem Pharmacol. 2015 Aug 1;96(3):237-46 - PubMed
    1. Diabetes. 2010 Dec;59(12):3099-107 - PubMed
    1. Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501 - PubMed
    1. Trends Pharmacol Sci. 2014 Jan;35(1):12-22 - PubMed

Publication types

MeSH terms